An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing

Journal of Neuro-Oncology

Volumn 108, Issue 1, 2012, Pages 29-35

  Aoki, Yasuyuki ^a   Hashizume, Rintaro ^a   Ozawa, Tomoko ^a   Banerjee, Anu ^a   Prados, Michael ^a   James, C David ^a   Gupta, Nalin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bioluminescence image; Brainstem glioma; Mouse model

Indexed keywords

6 ACETYL 8 CYCLOPENTYL 5 METHYL 2 [5 (1 PIPERAZINYL) 2 PYRIDINYLAMINO] 8H PYRIDO[2,3 D]PYRIMIDIN 7 ONE; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; PROTEIN SERINE THREONINE KINASE INHIBITOR; TEMOZOLOMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BRAIN STEM; CANCER SURVIVAL; CONTROLLED STUDY; DIFFUSE INFILTRATING PONTINE GLIOMA; DRUG EFFICACY; FEASIBILITY STUDY; FEMALE; GLIOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; SINGLE DRUG DOSE; TREATMENT RESPONSE; TUMOR CELL; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN STEM NEOPLASMS; CASPASE 3; DACARBAZINE; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUMINESCENT AGENTS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; PIPERAZINES; PONS; PONTINE GLIOMA; PYRIDINES; RETINOBLASTOMA PROTEIN; TIME FACTORS; TUMOR CELLS, CULTURED; UBIQUITIN-PROTEIN LIGASES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84860266270     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-011-0796-x     Document Type: Article

References (26)

1. R Sethi J Allen B Donahue M Karajannis S Gardner J Wisoff S Kunnakkat J Mathew D Zagzag K Newman A Narayana 2011 Prospective neuraxis MRI surveillance reveals a high risk of leptomeningeal dissemination in diffuse intrinsic pontine glioma J Neurooncol 102 1 121 127 10.1007/s11060-010-0301-y 20623246 10.1007/s11060-010-0301-y
2. OJ Becher D Hambardzumyan TR Walker K Helmy J Nazarian S Albrecht RL Hiner S Gall JT Huse N Jabado TJ MacDonald EC Holland 2010 Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma Cancer Res 70 6 2548 2557 10.1158/0008-5472.CAN-09-2503 20197468 10.1158/0008-5472.CAN-09-2503 1:CAS:528:DC%2BC3cXjtFygurw%3D
3. A Claes G Gambarota B Hamans O van Tellingen P Wesseling C Maass A Heerschap W Leenders 2008 Magnetic resonance imaging-based detection of glial brain tumors in mice after antiangiogenic treatment Int J Cancer 122 9 1981 1986 10.1002/ijc.23306 18081012 10.1002/ijc.23306 1:CAS:528:DC%2BD1cXkt1Chs7k%3D (Pubitemid 351441186)
4. D Hargrave U Bartels E Bouffet 2006 Diffuse brainstem glioma in children: critical review of clinical trials Lancet Oncol 7 3 241 248 10.1016/S1470-2045(06)70615-5 16510333 10.1016/S1470-2045(06)70615-5 (Pubitemid 43286454)
5. K Masui SO Suzuki R Torisu JE Goldman P Canoll T Iwaki 2010 Glial progenitors in the brainstem give rise to malignant gliomas by platelet-derived growth factor stimulation Glia 58 9 1050 1065 10.1002/glia.20986 20468047 10.1002/glia.20986
6. EB Dinca JN Sarkaria MA Schroeder BL Carlson R Voicu N Gupta MS Berger CD James 2007 Bioluminescence monitoring of intracranial glioblastoma xenograft: response to primary and salvage temozolomide therapy J Neurosurg 107 3 610 616 10.3171/JNS-07/09/0610 17886562 10.3171/JNS-07/09/0610 1:CAS:528: DC%2BD2sXhtVequrvK (Pubitemid 47451046)
7. JL Finlay S Zacharoulis 2005 The treatment of high grade gliomas and diffuse intrinsic pontine tumors of childhood and adolescence: a historical - and futuristic - perspective J Neurooncol 75 3 253 266 10.1007/s11060-005-6747-7 16195805 10.1007/s11060-005-6747-7 1:CAS:528:DC%2BD28XhtVynsLg%3D (Pubitemid 43023756)
8. R Hashizume T Ozawa SM Gryaznov AW Bollen KR Lamborn WH Frey 2nd DF Deen 2008 New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163 Neuro Oncol 10 2 112 120 10.1215/15228517-2007-052 18287341 10.1215/15228517-2007-052 1:CAS:528:DC%2BD1cXls1Gjs7w%3D
9. GH Huynh DF Deen FC Szoka Jr 2006 Barriers to carrier mediated drug and gene delivery to brain tumors J Control Release 110 2 236 259 10.1016/j.jconrel.2005.09.053 16318895 10.1016/j.jconrel.2005.09.053 1:CAS:528:DC%2BD2MXhtlert7jM (Pubitemid 41827478)
10. RG Thorne GJ Pronk V Padmanabhan WH Frey 2nd 2004 Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration Neuroscience 127 2 481 496 10.1016/j.neuroscience.2004.05.029 15262337 10.1016/j.neuroscience.2004. 05.029 1:CAS:528:DC%2BD2cXlvVSqurg%3D (Pubitemid 38950662)
11. R Hashizume T Ozawa EB Dinca A Banerjee MD Prados CD James N Gupta 2010 A human brainstem glioma xenograft model enabled for bioluminescence imaging J Neurooncol 96 2 151 159 10.1007/s11060-009-9954-9 19585223 10.1007/s11060-009- 9954-9
12. K Michaud DA Solomon E Oermann JS Kim WZ Zhong MD Prados T Ozawa CD James T Waldman 2010 Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts Cancer Res 70 8 3228 3238 10.1158/0008-5472.CAN-09-4559 20354191 10.1158/0008-5472.CAN-09- 4559 1:CAS:528:DC%2BC3cXkslShtb8%3D
13. Ozawa T, James CD (2010) Establishing intracranial brain tumor xenografts with subsequent analysis of tumor growth and response to therapy using bioluminescence imaging. J Vis Exp (41). doi: 10.3791/1986
14. M Edinger YA Cao YS Hornig DE Jenkins MR Verneris MH Bachmann RS Negrin CH Contag 2002 Advancing animal models of neoplasia through in vivo bioluminescence imaging Eur J Cancer 38 16 2128 2136 10.1016/S0959-8049(02) 00410-0 12387838 10.1016/S0959-8049(02)00410-0 1:STN:280:DC%2BD38njtValtw%3D%3D (Pubitemid 35223250)
15. G Prasad T Sottero X Yang S Mueller CD James WA Weiss MY Polley T Ozawa MS Berger DT Aftab MD Prados DA Haas-Kogan 2011 Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide Neuro Oncol 13 4 384 392 10.1093/neuonc/noq193 21317208 10.1093/neuonc/noq193 1:CAS:528:DC%2BC3MXnvFKktrs%3D
16. GE Dinse SW Lagakos 1982 Nonparametric estimation of lifetime and disease onset distributions from incomplete observations Biometrics 38 4 921 932 7168795 10.2307/2529872 1:STN:280:DyaL3s7nvFWmtQ%3D%3D
17. RPJ Peto 1972 Asymptotically efficient rank invariant procedures J R Stat Soc Ser A Stat Soc 135 185 207
18. M Malumbres M Barbacid 2009 Cell cycle, CDKs and cancer: a changing paradigm Nat Rev Cancer 9 3 153 166 10.1038/nrc2602 19238148 10.1038/nrc2602 1:CAS:528:DC%2BD1MXit1ans78%3D
19. M de Tayrac A Etcheverry M Aubry S Saikali A Hamlat V Quillien A Le Treut MD Galibert J Mosser 2009 Integrative genome-wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression Genes Chromosom Cancer 48 1 55 68 10.1002/gcc.20618 18828157 10.1002/gcc.20618
20. DW Fry PJ Harvey PR Keller WL Elliott M Meade E Trachet M Albassam X Zheng WR Leopold NK Pryer PL Toogood 2004 Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts Mol Cancer Ther 3 11 1427 1438 15542782 1:CAS:528:DC%2BD2cXpslCkt7c%3D
21. DW Parsons S Jones X Zhang JC Lin RJ Leary P Angenendt P Mankoo H Carter IM Siu GL Gallia A Olivi R McLendon BA Rasheed S Keir T Nikolskaya Y Nikolsky DA Busam H Tekleab LA Diaz Jr J Hartigan DR Smith RL Strausberg SK Marie SM Shinjo H Yan GJ Riggins DD Bigner R Karchin N Papadopoulos G Parmigiani B Vogelstein VE Velculescu KW Kinzler 2008 An integrated genomic analysis of human glioblastoma multiforme Science 321 5897 1807 1812 10.1126/science.1164382 18772396 10.1126/science.1164382 1:CAS:528:DC%2BD1cXhtFCrtLrE
22. GI Jallo M Penno L Sukay JY Liu B Tyler J Lee BS Carson M Guarnieri 2005 Experimental models of brainstem tumors: development of a neonatal rat model Child's Nervous System 21 5 399 403 10.1007/s00381-004-1100-6 15702357 10.1007/s00381-004-1100-6 (Pubitemid 41372163)
23. Lee J, Jallo GI, Guarnieri M, Carson BS Sr, Penno MB (2005) A novel brainstem tumor model: guide screw technology with functional, radiological, and histopathological characterization. Neurosurg Focus 18 (6A):E11
24. Q Liu R Liu MV Kashyap R Agarwal X Shi CC Wang SH Yang 2008 Brainstem glioma progression in juvenile and adult rats J Neurosurg 109 5 849 855 10.3171/JNS/2008/109/11/0849 18976074 10.3171/JNS/2008/109/11/0849
25. IM Siu BM Tyler JX Chen CG Eberhart UW Thomale A Olivi GI Jallo GJ Riggins GL Gallia 2010 Establishment of a human glioblastoma stemlike brainstem rodent tumor model J Neurosurg Pediatr 6 1 92 97 10.3171/2010.3.PEDS09366 20593994 10.3171/2010.3.PEDS09366
26. V Caretti I Zondervan DH Meijer S Idema W Vos B Hamans M Bugiani E Hulleman P Wesseling WP Vandertop DP Noske G Kaspers CF Molthoff T Wurdinger 2010 Monitoring of tumor growth and post-irradiation recurrence in a diffuse intrinsic pontine glioma mouse model Brain Pathol 10.1111/j.1750-3639.2010. 00468.x 21159008